Decentralized Finance Space Heats up With Launch of World’s First DeFi ETF

FN Media Group Presents Market Commentary   New York, NY – February 2, 2022 – The decentralized finance (DeFi) space is continuing to heat up, with the world’s first ever exchange traded fund (ETF) launching this month. Hashdex, a Brazilian asset manager, is launching an ETF fund in collaboration with CF Benchmarks to track […]

How the Introduction Of AI, VR, And AR Could Boost the Global 3D Animation Market

Palm Beach, FL – February 2, 2022 – News Commentary – VFX or Visual Effects are a way of mixing real film shooting with false or animated images. Almost every single movie these days uses VFX. Recent technological advancements in 3D animation technology have fueled the growth of High-Definition (HD) videos along with extensive […]

Consumer Interest Continues to Rise as CBD Sales Expected to Reach $16 Billion By 2026

Palm Beach, FL – February 2, 2022 – News Commentary – Brightfield Group recently released a report on the sales of cannabidiol (CBD) in the United States. According to the report, sales of CBD reached $5.3 billion in 2021, an increase of 15% over sales in 2020. The pandemic constrained CBD growth, with brands […]

Groundbreaking Clinical Trials Accelerating New Treatment Options for Pancreatic Cancer

Palm Beach, FL – February 2, 2022 – News Commentary – In the battle against pancreatic cancer, new and innovative clinical trials have become extremely critical. These trials offer patients early access to cutting-edge treatments that can lead to progress in research and hopeful for better outcomes.  Every treatment available today was originally researched, […]

Oncolytics Biotech® Provides Positive Safety Update on the Pancreatic Cancer Cohort of its Multi-Indication Phase 1/2 Gastrointestinal Cancer Trial

Independent safety review completed with no toxicity concerns   Cohort builds on prior proof-of-concept data demonstrating clinical benefit of pelareorep-checkpoint inhibitor combination in pancreatic cancer   Multi-indication trial being conducted in collaboration with Roche and AIO also includes cohorts in metastatic colorectal and advanced anal cancers   SAN DIEGO, CA and CALGARY, AB – February […]